홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Hydrochloric Acid → N-[3-methyl-N-(2,2-diphenylacetyl)-L-phenylalanyl]-S-trityl-L-cysteinamide

HRID 276727
노트
인쇄 미리보기

반응식

HRID 276727 반응식
COC(C1C=C(COC[C@@H:14]([NH:17][C:18](=[O:44])[C@H:19]([CH2:36][C:37]2[CH:42]=[CH:41][CH:40]=[C:39]([CH3:43])[CH:38]=2)[NH:20][C:21](=[O:35])[CH:22]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[C:15]#[N:16])C=CC=1)=O.O.[OH:46]N1C2C=CC=CC=2N=N1.CN1CCOCC1.CN(C)CCCN=C=NCC.Cl.[C:75]([S:94][CH2:95][C@@H](C(N)=O)N)([C:88]1[CH:93]=[CH:92][CH:91]=[CH:90][CH:89]=1)([C:82]1[CH:87]=[CH:86][CH:85]=[CH:84][CH:83]=1)[C:76]1[CH:81]=[CH:80][CH:79]=[CH:78][CH:77]=1>C(Cl)Cl>[CH3:43][C:39]1[CH:38]=[C:37]([CH:42]=[CH:41][CH:40]=1)[CH2:36][C@@H:19]([C:18]([NH:17][C:14](=[O:46])[C@H:15]([CH2:95][S:94][C:75]([C:76]1[CH:81]=[CH:80][CH:79]=[CH:78][CH:77]=1)([C:88]1[CH:89]=[CH:90][CH:91]=[CH:92][CH:93]=1)[C:82]1[CH:83]=[CH:84][CH:85]=[CH:86][CH:87]=1)[NH2:16])=[O:44])[NH:20][C:21](=[O:35])[CH:22]([C:29]1[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=1)[C:23]1[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 6

HCID 313Hydrochloric AcidHCID 79724-MethylmorpholineHCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 27960291-Hydroxybenzotriazole hydrateHCID 44432703(2R)-2-amino-3-((triphenylmethyl)sulfanyl)propanamideHCID 86608564N-[2-[(3-(methoxycarbonyl)phenyl)methoxy]-1(S)-cyanoethyl]-3-methyl-Nalpha-(2,2-diphenylacetyl)-L-phenylalaninamide

생성물 1

HCID 69266013N-[3-methyl-N-(2,2-diphenylacetyl)-L-phenylalanyl]-S-trityl-L-cysteinamide

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

To a solution of 3-methyl-N-(2,2-diphenylacetyl-L-phenylalanine (see example 302, 1.0 g, 2.68 mmol), 1-hydroxybenzotriazole hydrate (0.41 g, 2.68 mmol) and N-methylmorpholine (0.74 mL, 6.69 mmol) in CH2Cl2 (80 mL) is added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide.HCl (0.77 g, 4.02 mmol) in one portion. After stirring 30 minutes at room temperature, S-trityl-L-cysteinamide (0.97 g, 2.68 mmol) is added to the solution in one portion, and the solution is stirred for 16 hours. The solution is evaporated, and the residue partitioned between water (80 mL) and ethyl acetate (80 mL). The aqueous layer is washed with EtOAc (2×80 mL), and the combined organic layers are then washed with 1 N HCl (100 mL), saturated aqueous NaHCO3 (1×50 mL), water (1×50 mL) and brine (1×50 mL), dried over MgSO4, and evaporated. The residue is triturated with Et2O/hexane (1:1) to yield N-[3-methyl-N-(2,2-diphenylacetyl)-L-phenylalanyl]-S-trityl-L-cysteinamide as a white solid.

후처리

  1. stirringthe solution is stirred for 16 hours
  2. customThe solution is evaporated
  3. customthe residue partitioned between water (80 mL) and ethyl acetate (80 mL)
  4. washThe aqueous layer is washed with EtOAc (2×80 mL)
  5. washthe combined organic layers are then washed with 1 N HCl (100 mL), saturated aqueous NaHCO3 (1×50 mL), water (1×50 mL) and brine (1×50 mL)
  6. dry with materialdried over MgSO4
  7. customevaporated
  8. customThe residue is triturated with Et2O/hexane (1:1)

출처 및 근거

ORD 기록
ord-507de8f9dbad465ca60d6a9eda7c5cbc
출처 데이터셋
uspto-grants-2002_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06353017B1

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트